Engineered tRNA Restored a Missing Protein in Cystic Fibrosis Models

Researchers engineered transfer RNA and a lipid carrier to restore functional CFTR protein in cells, mice and patient-derived cystic fibrosis organoids carrying premature stop mutations. The platform could eventually address similar errors across many genes, but it remains preclinical and has not been tested as a treatment in people.